New Drugs! Ranolazine Approved without mortality benefit

Ranolozine: New Anti-Anginal Medicine that works by inhibiting Sodium Channels. Ranolozine does NOT affect Blood pressure or heart rate.  It inhibits short runs of ventricular tachycardia.


Hurrah for our FDA!!!! Another Cardiac drug approved WITHOUT evidence of mortality benefit and it ONLY costs $3,000   a year or HALF the per capita expenditure for health!! With so many ‘Routine Miracles’  you have GOT to wonder who got paid off to push this one through!!! Yippee!! Another drug with a GREAT mechanism that does….. uh….. well, my Sodium channels are inhibited.. and…. I know!!! It “Markedly decreases the incidence of CASH in your bank account!!!!”



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: